
### [NCIT:C3712](http://purl.obolibrary.org/obo/NCIT_C3712)
**Label:** Squamous Papilloma

**Subclasses:** [NCIT:C4355](http://purl.obolibrary.org/obo/NCIT_C4355) (Eyelid Squamous Cell Papilloma), [NCIT:C6038](http://purl.obolibrary.org/obo/NCIT_C6038) (Oropharyngeal Squamous Papilloma), [NCIT:C4369](http://purl.obolibrary.org/obo/NCIT_C4369) (Nasal Vestibule Squamous Papilloma), [NCIT:C6376](http://purl.obolibrary.org/obo/NCIT_C6376) (Vestibular Papilloma), [NCIT:C6342](http://purl.obolibrary.org/obo/NCIT_C6342) (Cervical Squamous Papilloma), [NCIT:C4462](http://purl.obolibrary.org/obo/NCIT_C4462) (Squamous Cell Skin Papilloma), [NCIT:C6037](http://purl.obolibrary.org/obo/NCIT_C6037) (Squamous Papilloma of the Nasopharynx), [NCIT:C7742](http://purl.obolibrary.org/obo/NCIT_C7742) (Squamous Papilloma of the Larynx), [NCIT:C6224](http://purl.obolibrary.org/obo/NCIT_C6224) (Conjunctival Squamous Papilloma), [NCIT:C5344](http://purl.obolibrary.org/obo/NCIT_C5344) (Esophageal Squamous Papilloma), [NCIT:C6374](http://purl.obolibrary.org/obo/NCIT_C6374) (Vaginal Squamous Papilloma), [NCIT:C65165](http://purl.obolibrary.org/obo/NCIT_C65165) (Inverted Squamous Cell Papilloma), [NCIT:C5819](http://purl.obolibrary.org/obo/NCIT_C5819) (Buccal Mucosa Papilloma), [NCIT:C40290](http://purl.obolibrary.org/obo/NCIT_C40290) (Vestibular Micropapillomatosis), [NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma), 

**Class expressions from DL-Learner:**

- Thing 53.40%
- [NCIT:C47826](http://purl.obolibrary.org/obo/NCIT_C47826) (Diffuse Lesion) 52.78%
- [NCIT:C41608](http://purl.obolibrary.org/obo/NCIT_C41608) (Endocrine-Stromal Cell) 52.78%
- [NCIT:C36116](http://purl.obolibrary.org/obo/NCIT_C36116) (Borderline Lesion) 52.78%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39573](http://purl.obolibrary.org/obo/NCIT_C39573) (T-Lymphocyte with a Post-Thymic Immunophenotype))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39572](http://purl.obolibrary.org/obo/NCIT_C39572) (Neoplastic Cerebriform T-Prolymphocyte))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39571](http://purl.obolibrary.org/obo/NCIT_C39571) (Neoplastic Small T-Prolymphocyte))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39569](http://purl.obolibrary.org/obo/NCIT_C39569) (Cytoplasmic Protrusions Present))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39565](http://purl.obolibrary.org/obo/NCIT_C39565) (Coarse Azurophilic Granules Present))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3950](http://purl.obolibrary.org/obo/NCIT_C3950) (Oral Mucosa Lobular Capillary Hemangioma))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C3939](http://purl.obolibrary.org/obo/NCIT_C3939) (Bannayan Syndrome))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39301](http://purl.obolibrary.org/obo/NCIT_C39301) (CD4+/CD56+ Neoplastic Medium-Sized Cell))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39300](http://purl.obolibrary.org/obo/NCIT_C39300) (Precursor Natural Killer Cell))) 38.13%
- [NCIT:C42624](http://purl.obolibrary.org/obo/NCIT_C42624) (Premalignant Lesion) and (not ([NCIT:C39294](http://purl.obolibrary.org/obo/NCIT_C39294) (Schistosoma Hematobium Infection))) 38.13%


